The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: A registry-based cohort study

British Journal of Cancer

Volumn 109, Issue 1, 2013, Pages 265-271

  Grann, A F ^a   Froslev T ^a   Olesen, A B ^a   Schmidt, H ^a   Lash, T L ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CHILD; COHORT ANALYSIS; COMORBIDITY; DENMARK; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEWBORN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REGIONAL METASTASIS; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HUMANS; INFANT; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84880293440     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.246     Document Type: Article

References (38)

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm Jr. MC, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36): 6199-6206.
2. Birch-Johansen F, Hvilsom G, Kjaer T, Storm H (2008) Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994-2003. Eur J Cancer 44(14): 2043-2049.
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5): 373-383.
4. Cronin-Fenton DP, Norgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sorensen HT (2007) Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 96(9): 1462-1468.
5. de Vries E, Coebergh JW (2004) Cutaneous malignant melanoma in Europe. Eur J Cancer 40(16): 2355-2366.
6. Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146(Suppl 61): 1-6.
7. Documentation of the Cancer Registry (2009) (Dokumentation af cancerregistret), Available at http://www.ssi.dk/Sundhedsdataogit/ Registre/Cancerregisteret.aspx.
8. Extermann M (2007) Interaction between comorbidity and cancer. Cancer Control 14(1): 13-22.
9. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287(5462): 2398-2399.
10. Froslev T, Grann AF, Olsen M, Olesen AB, Schmidt H, Friis S, Sogaard M (2012) Completeness of TNM cancer staging for melanoma in the Danish Cancer Registry, 2004-2009. Clin Epidemiol 4(Suppl 2): 5-10.
11. Garbe C, Leiter U (2009) Melanoma epidemiology and trends. Clin Dermatol 27(1): 3-9.
12. Gonzalez EC, Ferrante JM, Van Durme DJ, Pal N, Roetzheim RG (2001) Comorbid illness and the early detection of cancer. South Med J 94(9): 913-920.
13. Jorgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7): 1353-1360.
14. Kaae J, Wohlfahrt J, Boyd HA, Wulf HC, Biggar RJ, Melbye M (2007) The impact of autoimmune diseases on the incidence and prognosis of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 16(9): 1840-1844.
15. Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, Herr HW, Bochner BH (2008) Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 112(11): 2384-2392.
16. Land LH, Dalton SO, Jensen MB, Ewertz M (2011) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat 131(3): 1013-1020.
17. Lasithiotakis KG, Petrakis IE, Garbe C (2010) Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Melanoma Res 20(3): 163-170.
18. Leiter U, Garbe C (2008) Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 624: 89-103.
19. Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150(2): 179-185.
20. Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41(5): 779-785.
21. Lund L, Borre M, Jacobsen J, Sorensen HT, Norgaard M (2008) Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study. Urology 72(6): 1258-1262.
22. Mazzola P, Radhi S, Mirandola L, Annoni G, Jenkins M, Cobos E, Chiriva-Internati M (2012) Aging, cancer, and cancer vaccines. Immun Ageing 9(1): 4.
23. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson III AB, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21(3): 433-440.
24. Moehrle M (2008) Outdoor sports and skin cancer. Clin Dermatol 26(1): 12-15.
25. Norgaard C, Glud M, Gniadecki R (2011) Are all melanomas dangerous? Acta Derm Venereol 91(5): 499-503.
26. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14): 1101-1111.
27. Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ (2006) Effect of obesity on survival in epithelial ovarian cancer. Cancer 107(7): 1520-1524.
28. Schmidt H, Larsen S, Bastholt L, Fode K, Rytter C, von der MH (2002) A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma. Ann Oncol 13(12): 1919-1924.
29. SEER (2012) Surveillance Epidemiology and End Results. National Cancer Institute. Available at http://seer.cancer.gov/.
30. Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 44(5): 535-539.
31. Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M (2008a) The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer 8: 31.
32. Tetsche MS, Norgaard M, Jacobsen J, Wogelius P, Sorensen HT (2008b) Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study. Int J Gynecol Cancer 18(3): 421-427.
33. The Danish Cancer Registry (2010) Cancerregistret 2010Available at http:// www.sst.dk/publ/Publ2011/DAF/Cancer/Cancerregisteret2010.pdf.
34. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT (2011) The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 11: 83.
35. Tryggvadottir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, Bray F (2010) Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 49(5): 665-672.
36. Wedding U, Roehrig B, Klippstein A, Steiner P, Schaeffer T, Pientka L, Hoffken K (2007) Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol 61(3): 269-276.
37. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B (2008) Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 46(7): 1078-1084.
38. West DW, Satariano WA, Ragland DR, Hiatt RA (1996) Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 6(5): 413-419.